203 related articles for article (PubMed ID: 33637370)
1. Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam.
Shao CH; Tai CH; Lin FJ; Wu CC; Wang JT; Wang CC
J Formos Med Assoc; 2022 Jan; 121(1 Pt 1):117-125. PubMed ID: 33637370
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
[TBL] [Abstract][Full Text] [Related]
3. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.
Aslan AT; Pashayev T; Dağ O; Akova M
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1953-1961. PubMed ID: 33884515
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Alosaimy S; Lagnf AM; Hobbs ALV; Mubarez M; Kufel WD; Morrisette T; Polisetty RS; Li D; Veve MP; Simon SP; Truong J; Finch N; Venugopalan V; Rico M; Amaya L; Yost C; Cubillos A; Chandler E; Patch M; Smith IMK; Biagi M; Wrin J; Moore WJ; Molina KC; Rebold N; Holger D; Kunz Coyne AJ; Jorgensen SCJ; Witucki P; Tran NN; Davis SL; Sakoulas G; Rybak MJ
Clin Infect Dis; 2023 Feb; 76(3):e1444-e1455. PubMed ID: 35982631
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of teicoplanin-based combination therapy: focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams.
Tai CH; Shao CH; Wang CC; Lin FJ; Wang JT; Wu CC
J Antimicrob Chemother; 2021 Jan; 76(2):499-506. PubMed ID: 33152760
[TBL] [Abstract][Full Text] [Related]
6. Impact of combining vancomycin with piperacillin/tazobactam or with meropenem on vancomycin-induced nephrotoxicity.
Tookhi RF; Kabli NA; Huntul MA; Thabit AK
Intern Emerg Med; 2021 Jun; 16(4):975-979. PubMed ID: 33439417
[TBL] [Abstract][Full Text] [Related]
7. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
Carreno J; Smiraglia T; Hunter C; Tobin E; Lomaestro B
Int J Antimicrob Agents; 2018 Nov; 52(5):643-650. PubMed ID: 30103003
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Rutter WC; Burgess DS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
10. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
[TBL] [Abstract][Full Text] [Related]
11. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Balcı C; Uzun Ö; Arıcı M; Hayran SA; Yüce D; Ünal S
Int J Antimicrob Agents; 2018 Aug; 52(2):180-184. PubMed ID: 29649586
[TBL] [Abstract][Full Text] [Related]
13. Piperacillin-Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
Aslan AT; Akova M
Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011239
[TBL] [Abstract][Full Text] [Related]
14. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
[TBL] [Abstract][Full Text] [Related]
15. Effect modification of dosing strategy (AUC or trough) on AKI associated with vancomycin in combination with piperacillin/tazobactam or cefepime and meropenem.
Mefford B; Wallace KL; Donaldson JC; Bissell Turpin BD; Sen P; Schadler AD; Liu LJ; Thompson Bastin ML
Antimicrob Agents Chemother; 2024 May; 68(5):e0108523. PubMed ID: 38606975
[TBL] [Abstract][Full Text] [Related]
16. Acute Kidney Injury in Non-Intensive Care and Intensive Care Patients Treated with Vancomycin and Piperacillin-Tazobactam.
Inage S; Nakamura S; Isoe Y; Okamoto S; Uetake S; Murakami M; Yamaguchi A; Morishima M; Nei T; Ise Y; Katayama S
J Nippon Med Sch; 2020 May; 87(2):66-72. PubMed ID: 31611508
[TBL] [Abstract][Full Text] [Related]
17. Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.
He M; Souza E; Matvekas A; Crass RL; Pai MP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526494
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
Komerdelj IA; Buckley MS; D'Alessio PA; Ziadat DS; Kobic E; Rangan P; Agarwal SK; Tinta NC; Yerondopoulos MJ; Kane-Gill SL
J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
[No Abstract] [Full Text] [Related]
19. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Buhlinger KM; Fuller KA; Faircloth CB; Wallace JR
Am J Health Syst Pharm; 2019 Aug; 76(16):1204-1210. PubMed ID: 31369115
[TBL] [Abstract][Full Text] [Related]
20. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
Liu K; Zhang Y; Xu X; Wu B; Ni J; Li T; Xing C; Mao H
Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]